Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma
Author:
Funder
III
CNS
Roche
UM
JC
Celgene
Gilead
Novartis
A.P. Møller og hustru Chastine Mc-Kinney Møllers Fond til almene formal (TCEG)
UF
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference43 articles.
1. Influence of rituximab on central nervous system relapse in diffuse large B-Cell lymphoma and role of prophylaxis–a systematic review of prospective studies;Ghose;Clin Lymphoma Myeloma Leuk,2015
2. Diffuse large B-cell lymphoma with involvement of the kidney: outcome and risk of central nervous system relapse;Villa;Haematologica,2011
3. Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy;Villa;Ann Oncol,2010
4. The impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL;Savage;Blood,2016
5. CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the Mabthera International Trial and trials of the German High-Grade Non-Hodgkin Lymphoma Study Group;Schmitz;Ann Oncol,2012
Cited by 87 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Two-year follow-up of lisocabtagene maraleucel in relapsed or refractory large B-cell lymphoma in TRANSCEND NHL 001;Blood;2024-02-01
2. Secondary central nervous system involvement in patients with diffuse large B-cell lymphoma treated with rituximab combined CHOP therapy – a supplementary analysis of JCOG0601;Annals of Hematology;2024-01-27
3. Sustained efficacy of chimeric antigen receptor T-cell therapy in central nervous system lymphoma: a systematic review and meta-analysis of individual data;Frontiers in Pharmacology;2024-01-24
4. Comparison of standardized prophylactic high-dose and intrathecal methotrexate for DLBCL with a high risk of CNS relapse;International Journal of Hematology;2024-01-17
5. A prospective observational study of real-world treatment and outcome in secondary CNS lymphoma;European Journal of Cancer;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3